Document Detail

The Three Integrated Phases of Left Atrial Macrophysiology and Their Interactions.
Jump to Full Text
MedLine Citation:
PMID:  25167138     Owner:  NLM     Status:  Publisher    
Our understanding of the left atrium is growing, although there are many aspects that are still poorly understood. The left atrium size as an imaging biomarker has been consistently shown to be a powerful predictor of outcomes and of different cardiovascular disorders, such as, but not limited to, atrial fibrillation, congestive heart failure, mitral regurgitation and stroke. Left atrial function has been conventionally divided into three integrated phases: reservoir, conduit and booster-pump. The highly dynamic left atrium and its response to the stretch and secretion of atrial neuropeptides leaves the left atrium far from being a simple transport chamber. The aim of this review is to provide an understanding of the left atrial physiology and its relation to disorders within the heart.
Raman Mehrzad; Mohammad Rajab; David H Spodick
Related Documents :
22645368 - Heart wall myofibers are arranged in minimal surfaces to optimize organ function.
689828 - Uptake of contrast materials by experimental acute myocardial infarctions: a preliminar...
15033158 - Myocardial infarction in the c57bl/6j mouse: a quantifiable and highly reproducible exp...
16953248 - From the origin of species to the origin of bacterial flagella.
7960248 - Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase:...
1704978 - Reentrant tachycardia in a thin layer of ventricular subepicardium: effects of d-sotalo...
Publication Detail:
Type:  REVIEW     Date:  2014-8-27
Journal Detail:
Title:  International journal of molecular sciences     Volume:  15     ISSN:  1422-0067     ISO Abbreviation:  Int J Mol Sci     Publication Date:  2014  
Date Detail:
Created Date:  2014-8-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101092791     Medline TA:  Int J Mol Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  15146-15160     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Int J Mol Sci
Journal ID (iso-abbrev): Int J Mol Sci
Journal ID (publisher-id): ijms
ISSN: 1422-0067
Publisher: MDPI
Article Information
Download PDF
© 2014 by the authors; licensee MDPI, Basel, Switzerland.
Received Day: 26 Month: 6 Year: 2014
Revision Received Day: 17 Month: 8 Year: 2014
Accepted Day: 21 Month: 8 Year: 2014
Electronic publication date: Day: 27 Month: 8 Year: 2014
collection publication date: Month: 9 Year: 2014
Volume: 15 Issue: 9
First Page: 15146 Last Page: 15160
PubMed Id: 25167138
ID: 4200839
DOI: 10.3390/ijms150915146
Publisher Id: ijms-15-15146

The Three Integrated Phases of Left Atrial Macrophysiology and Their Interactions
Raman Mehrzad1*
Mohammad Rajab2
David H. Spodick3
1Department of Medicine, Steward Carney Hospital, Tufts University School of Medicine, 2100 Dorchester Avenue, Boston, MA 02124, USA
2Department of Medicine, Division of Cardiology, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA; E-Mail:
3Department of Medicine, Division of Cardiology, St. Vincent Hospital, University of Massachusetts Medical School, Worcester, MA 02124, USA; E-Mail:
*Author to whom correspondence should be addressed; E-Mail:; Tel.: +1-774-240-0060.

1. Introduction—Compelling Physiology

The vastly dynamic left atrium (LA) and its response to the stretch and secretion of atrial neuropeptides leaves the LA far from being a simple transport chamber. Partial adjustment of fluid and hemodynamic balance is allowed by a balance of natriuresis, vasodilatation, and inhibition of the sympathetic and renin-angiotensin-aldosterone systems [1,2,3]. Furthermore, LA enlargement predicts stroke, transient ischemic attack (TIA), congestive heart failure (CHF), atrial fibrillation (AF) and other adverse cardiovascular outcomes [4,5,6]. Left atrial function has been typically divided into three integrated phases: reservoir, conduit and booster-pump (Figure 1) [7,8,9,10]. Reservoir: an expansion phase during left ventricular (LV) systole; the LA stores pulmonary venous return during LV contraction and isovolumic relaxation. Conduit: the LA transfers blood passively into the LV during ventricular diastole. Booster-pump: contractile component (when supraventricular rhythm is present); the LA actively contracts during the final phase of diastole and contributes between 15% and 30% of LV stroke volume [7,8,9,10]. Since the LA empties into the LV, size and function are very much dependent on the compliance of the LV, especially during diastole. In patients with ventricular dysfunction, the active contractile component of the LA has an important role to augment (“boost”) ejection force and stroke volume by increasing end-diastolic volume and pressures. In addition, in patients with reduced ventricular compliance, augmented left atrial booster function is one of the mechanisms compensating for decreased early filling. Diseases such as AF or in unsynchronized ventricular pacing, the loss of atrial contraction contributes to 20% reduction in cardiac output [11,12].

Increased reservoir function may play an important role in accelerating LV filling by helping to maintain an enhanced atrioventricular pressure gradient during diastole and also by increasing LA booster function through increased preload. This is supported by the LA reservoir and booster functions when augmented during exercise, whereas conduit function is not [13]. The conduit function of the LA increases when there is an isolated decrease in LA compliance. The ability to optimally redistribute LV filling among reservoir, conduit and booster-pump functions are a potentially important adaptation that may occur in the LA in response to changing hemodyanmics [14].

2. Adaptation

Left atrial preload is mainly volume dependent [13,15,16]; however, LA afterload is determined largely by its elastic properties and decreased LV pressure, as it increases with more severe LV diastolic dysfunction and elevated LV filling pressure [17]. When LA volume and pressure increase, there is an enlargement in LA size and concurrent gain in contractile shortening in the initial phase. Nevertheless, atrial fiber shortening and contractility begin to fail with progressive dilation of the LA, because it eventually leads to a threshold fiber length [18,19,20,21,22,23,24,25]. There are similar effects in the LV Frank-Starling curve, since beyond this threshold effect, further enlargement will only result in a decline of atrial function [26].

There is a dynamic and interactive relationship between LV and LA, evidenced by studies characterizing aging, athletic training, and multiple disease states [24,27,28,29]. Aging: In normal healthy subjects, LA volume index remains stable until the eighth decade despite the impaired LV diastolic relaxation that is apparent in the sixth decade, however, the latter is associated with a shift in phasic LA volumes, so that LA expansion index and passive emptying decrease while the active emptying volume increases [30]. Athletes: In contrast to aging, exercise increases the LA volume index, active and passive emptying in correlation with an improvement in LV diastolic properties, an increase in LV indexed mass and an increase in stroke volume. Thus, LA remodeling occurs in association with LV remodeling, and such LA enlargement represents the physiologic consequence of a global cardiac adaptation to the increased stroke volume associated with chronic and intensive exercise conditioning [31].

Lastly, the significant improvement in LA volume and function that is met after sinus rhythm is achieved with radiofrequency ablation for paroxysmal AF [32,33] or cardioversion of AF [34] is also evidence of the dynamic aspect of LA function and morphology.

3. Left Atrial Appendage: A Sometimes Deadly Attachment

Interestingly, the left atrial appendage (LAA) is embryologically and functionally distinct from the LA proper [35]. The LAA is derived from the LA and forms a blind pouch approximately 2–4 cm long. The neck of the LAA is relatively narrow and the endocardial surface is irregular due to pectinate muscles. It has been described as our most lethal human attachment [36]. It is closely related in its superior aspect to the pulmonary artery and inferomedially to the free wall of the left ventricle. As the left ventricle dilates during diastole, it fills the intrapericardial space, and it has been suggested that it may contribute to appendiceal emptying by compressing the inferomedial wall of the LAA between its free wall and the fixed pericardium [37]. In addition, ventricular filling creates an intracavitary suction effect, influencing emptying and filling of the atrium and consequently the appendage. The extent of emptying and filling of the LAA may be influenced more by changes in LV rather than LAA function [38]. This is a finding that could in part help to explain the higher incidence of AF-related stroke in patients with left ventricular dysfunction [39]. Moreover, in persistent AF, the strongest predictor of LAA thrombus is an increased left ventricular size [40].

Animal studies suggest that the LAA is more distensible than the LA proper [41]. In humans, clamping of the LAA during cardiac surgery results in an increase in LA pressure and dimension, as well as in transmitral and pulmonary diastolic flow velocities [42]. Because of its increased distensibility, the LAA may augment hemodynamic function by modulating LA pressure–volume relations in states of increased LA pressure and volume overload [43]. Atrial appendages contain about 30% of all the cardiac atrial natriuritic factor [44]. Both appendages can be selectively distended without altering the pressures in the right or left atrium or aorta, and distention causes an increase in heart rate (a reflex response with a vagal afferent path and a sympathetic efferent path) [45]. The presence of numerous myocardial stretch receptors in the LA, together with the fact that wall stress is amplified in the LAA due to its geometry, LAA becomes a more sensitive gauge of pressure changes than the LA proper [46].

The role of the LAA is most notable in AF and thromboembolic stroke [46]. Among those patients who sustained thromboembolic stroke, low flow velocities, spontaneous echo contrast, and thrombus have been identified in the LA appendage [31,47,48,49]. Atrial appendage flow velocities are often <50 cm/s in patients with AF, and this feature has been associated with thrombus formation and stroke [35]. As a strategy to lower thromboembolic events in AF patients, device closure of the LAA has been tested, and preliminary data suggest LAA occlusion with this system to be safe [50].

4. Frank-Starling Mechanism

Cardiac output (CO) increases in response to an increase in blood volume within the heart chambers. The increase in blood volume stretches the myocardial fibers, causing the cardiac muscle to contract more forcefully with increase in its mechanical performance. Intraatrial pressure controls atrial stretch. The Frank-Starling mechanism in the atrium is manifested in two phases. An increase in the amplitude of the calcium transient and a decrease in the time constant of Ca2+ transient decay are accompanied by the development of increased contraction force after stepwise increase of stretch. Thus, immediately after the stretch, the contraction force is increased, and an additional increase in force is followed instantly afterwards. An increase in muscle length results in a gradual augmentation of Ca2+ transient amplitude, which modulates the action potentials through increased Na+/Ca2+-exchange inward current. Troponin C is the calcium binding part of the contractile machinery, and is sensitive to muscle length. Experiments show that troponin C affinity change is needed to produce the immediate increase of contraction force and stretch, modulate the Ca2+ transient and stabilize the diastolic Ca2+ concentration [51]. The same mechanism that caused the normal physiologic responses to stretch could also generate arrythmogenic after potentials at high stretch levels in the model. Using a bivariate regression model with the assumption that variability is constant as a percentage of the expected value, a regression equation and graphs was developed that allowed calculation of a 95% prediction interval for several echocardiographic measurements as a function of the subject’s age and either body weight or body surface area [52].

With a stepwise decrease in the pacing heart rate, the LA dimension increases just before atrial contraction, and LA systolic shortening increases as well. Nevertheless, a decrease in the left ventricular filling volume during atrial systole is seen. As the pulmonary venous flow during atrial systole is directed toward the left atrium, the left atrial inflow volume from the pulmonary venous flow decreases, and the Frank-Starling mechanism operates with a decrease in the pacing rate. However, due to the decrease in pulmonary venous flow to the left ventricle via the left atrium, left ventricular filling decreases [53].

5. Left Atrial Distensibility

Left atrial relaxation, stiffness and contractility influence LA reservoir, conduit and contraction function. Furthermore, LA distensibility has prognostic significance in different cardiovascular diseases such as congestive heart failure (CHF), myocardial infarction and mitral regurgitation [54].

A study with 56 untreated patients in sinus rhythm, including 25 with previous myocardial infarction, 9 with hypertrophic cardiomyopathy, 11 with dilated cardiomyopathy, as well as 11 with chest pain syndrome as controls was done [55]. Peak first systolic velocity (PVS1), peak atrial systolic velocity (PVA), and their time-velocity integrals (PVS1-I and PVA-I, respectively) were calculated from the pulmonary venous flow velocity. Their analyses indicated that the peak first systolic velocity was closely related to percentage fractional LA relaxation, followed by mean pulmonary capillary wedge pressure. The peak first systolic velocity determined from the pulmonary venous flow velocity is closely related to parameters of LA relaxation, which may be determined by transesophageal echocardiography, and the ratio of peak atrial systolic velocity to peak first systolic velocity is useful for non-invasive evaluation of the LA pressure [55].

In vivo, regional differences in atrial distensibility may play an important role in modulating systolic and diastolic function of the LA. In the presence of LA pressure and/or volume overload, LAA becomes more compliant than the LA main chamber. Pericardiectomy increases LA compliance and early left ventricular filling rate and is accompanied by a relatively greater augmentation in conduit than reservoir function of the LA [56].

6. Pathological Changes
6.1. Left Atrial Function and Neuroendocrine Dependence

Control of heart rate, blood pressure, cardiac output, and regional blood flow are all affected by neurohormonal regulation [57]. In patients with CHF, plasma concentrations of brain natriuritic peptide, ANP, noradrenaline, renin and angiotensin-II are increased to compensate for the systemic failure caused by the heart. However, chronic activation of these hormones can cause negative cardiovascular effects such as LA remodeling and reduce atrial contractility with proarrhythmic and prothrombotic effects accordingly [58,59,60,61,62,63,64].

6.2. Atrial Fibrillation

Since synchronized atrial contraction is lost during AF, cardiac output will decline subsequently. To compensate for the decrease in stroke volume, the atrial pressure increases [65]. Moreover, after the introduction of AF, the diastolic atrial compliance decreases in both right and left atria [66]. Due to the hemodynamic load from the increase in atrial pressure, the size of the LA increases which in turn predisposes to AF [67]. Nevertheless, AF itself can result in atrial enlargement. Studies show that the LA is slightly dilated in patients with paroxysmal AF [68], and in patients with lone AF, a slow progressive enlargement of the LA size is usually noted independent of any changes in ventricular size or function [69]. As a consequence of left atrial enlargement, it may convey additional risk of stroke in patients with AF [70]. Thus, enlargement of the LA plays a role in AF, and therefore maintenance of sinus rhythm is important to prevent complications [71].

6.3. Importance of the Left Atrial Appendage

The LAA is a remnant of the original embryonic LA. Its interest has grown over the past years mostly due to the mechanical antithrombotic intervention strategies. The LAA has been found to be the source of >90% of thrombi in patients with nonvalvular AF [72]. Thus, prevention of thrombus formation by “eliminating” the LAA, through various methods is a novel therapeutic target for stroke prevention, especially in patients with contraindications to anticoagulation therapy [73]. However, LAA is important in regulating intravascular volume status and hemodynamic conditions such as mediating thirst, maintaining cardiac output, release of ANP and could not be a useless appendage [74].

6.4. Mitral Valve Disease

Left atrium function is influenced by changes in LA afterload. In patients with mitral stenosis (MS), the obstructed valve leads to a pressure gradient across the valve in diastole which causes an elevation in LA pressure and LA dilatation [11].

This early increase in LA pressure leads to LA enlargement, predisposing patients to AF and systemic embolism [75]. The increase in heart rate, as a result of new onset AF, leads to reduced CO. However, the atrial booster-pump function contributes less to ventricular filling in MS than in the normal heart, and the loss of atrial pump function is less important than the effect of increasing heart rate as the cause of decompensation during AF [76].

In acute mitral regurgitation (MR), the LA pressure increases quickly with atrial shortening and chamber dilatation as a result of the atrial muscle’s use of the Frank-Starling mechanism. The geometry of the mitral opening highly affects the degree of regurgitation, and a decrease in back-flow of blood with vasodilator therapy or with positive inotropic agents may be largely related to a decrease in the size of the left ventricle cavity. This brings components of the mitral apparatus closer together and increases its functional capability [77].

During chronic MR, a gradual increase in LA size is noted and this enables a more effective booster-pump function. However, LA pressure increases in the late phase of the disease, which leads to subsequent LA enlargement that predispose to AF, thromboembolism, pulmonary hypertension and right-sided heart failure as long term complication [14].

6.5. Hypertension

Hypertension is associated with left ventricular hypertrophy, myocardial fibrosis and alteration in calcium handling [78,79], which ultimately would lead to relaxation disorder and diastolic dysfunction [80,81]. As a consequence, blood flow from the LA is impaired which lead to LA enlargement. This phenomenon is well documented even in early hypertension [82]. Left ventricular mass and severity of diastolic dysfunction have been positively correlated to the size of LA [83,84,85]. Hypertension “accelerates” the normal aging process of the LA. Hypertensive patients as early as decade four, have similar LA size to that of normal controls in decade eight. This premature increase in LA volume increases the risk of AF development in hypertensive patients [4,83,86]. Hypertension also has been shown to decrease LA strain, a marker of LA reservoir function, and this is independent of LV hypertrophy. However, this decrease in reservoir function can be normalized with the use of renin-angiotensin system inhibitors if atrial enlargement has not yet occurred [87].

6.6. Myocardial Infarction

Left ventricular ejection fraction is usually decreased with myocardial infarction of the left ventricle. However, despite this decrease in ejection fraction, the stroke volume is usually maintained by an increase in left atrial booster function, resulting in remarkable rise in end-diastolic left ventricular volume. This inverse relationship in function between the LV and LA has been manifested by a significant increase in LA contractility during a decrease in LV peak systolic pressure and dp/dtmax [88]. The average atrial contribution to LV end-diastolic volume was 11.9% in normal subject compared to15.4% in patients with myocardial infarction; while the contribution to the LV stroke volume was 21.7% vs. 35.1%, respectively [89]. The above contribution could only be seen if the LA is not affected by the same ischemic event as it could happen during proximal left circumflex artery stenosis that render the LA ischemic and unable to augment its booster-pump function which exacerbates hemodynamic compromise [90]. However, with further LA enlargement and substantial increases in LA pressure, these compensatory mechanisms fail. Subsequently LA stroke volume increases causing augmented passive emptying [23,91] whilst contractile function is reduced [11]. Furthermore, increased LA volume index following an acute myocardial infarction was shown to be an independent predictor of mortality, independent of clinical variables and LV systolic and diastolic function [92].

6.7. Congestive Heart Failure

As mentioned above, LA reservoir and increased contractility counterbalance the initial impairment in LV filling. However, as the LV dysfunction progresses, these mechanisms become of limited effect and are replaced by the conduit function of the LA [23]. This could happen when the near-maximum left ventricular diameter is reached early in diastole with increased preload, rendering atrial contraction of little contribution to end diastolic ventricular volume [93].

In patients with idiopathic cardiomyopathy, compared to ischemic cardiomyopathy, atrial reservoir and contractile function were differentially reduced in the idiopathic cardiomyopathy group, highlighting the more generalized involvement of left atrium and ventricle in idiopathic cardiomyopathy [94].

Patients with hypertrophic cardiomyopathy have reduced atrial strain for all phases of atrial function, whilst atrial contractile function had an additive prognostic value in predicting the type of LV hypertrophy [95]. Additionally, strain derived atrial contractile function was the only independent predictor of heart failure symptoms (by the New York Heart Association class) in patients with hypertrophic cardiomyopathy [96].

6.8. Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) contributes to the deterioration of LV diastolic function that can lead to atrial myocardial overstretching and enlargement, which could be associated with increased cardiovascular risk [97]. OSA causes a significant increase in LA volume that correlates with the severity of the disease, the more obstruction the larger LA volume. In addition, OSA causes a reduction in average and lateral mitral annular early diastolic velocities with an increase in average and lateral late diastolic velocities [98].

7. Conclusions

LA function is not fully investigated and in some aspects poorly understood. However, it has a powerful role in the cardiovascular system and in various heart disorders, and a growing understanding is crucial. Our review attempts to investigate the physiology of the LA and its associations in disease states. Consequently, in disease conditions, the LA augments failing left ventricular filling, and the LA may undergo failure itself. On this basis, LA function should be assessed since this might contribute to the evaluation of the current disease state, severity and outcome. Through different techniques, LA function can be evaluated in normal subjects, and in patients at rest or after pharmacological interventions. By measuring LA dimension and pressure one can evaluate LA function. An increase in the LA dimension and pressure and shift of the LA pressure-dimension curve with a parallel decrease in LA stroke work indicates LA dysfunction. After pharmacological interventions, changes in LV filling are attributed not only to LV diastolic function improvement but also to coordinated changes in LA function. The compensatory response to decreased early filling is increased atrial kick. An increased load on the LA, which may cause intrinsic LA dysfunction, can result in loss of kick. Left atrium dysfunction decreases LV filling in patients with LV dysfunction.


We would like to thank Melorin Mehrzad, a dental student, who helped with the data collection.

Author Contributions

All authors reviewed the scientific literature, interpreted the data, and wrote the manuscript.


LA, Left atrium; CO, Cardiac output; CHF, Congestive heart failure; AF, Atrial fibrillation; LV, Left ventricle; MS, Mitral stenosis; MR, Mitral regurgitation; and OSA, Obstructive sleep apnea.

Conflicts of Interest

The authors declare no conflict of interest.

1.. Garcia M.J.. Left ventricular fillingHeart Fail. Clin.Year: 20084475610.1016/j.hfc.2007.10.00518313624
2.. Potter L.R.,Yoder A.R.,Flora D.R.,Antos L.K.,Dickey D.M.. Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applicationsHandb. Exp. Pharmacol.Year: 200919134136610.1007/978-3-540-68964-5_1519089336
3.. Serra J.L.,Bendersky M.. Atrial fibrillation and renin-angiotensin systemTher. Adv. Cardiovasc. Dis.Year: 2008221522310.1177/175394470809211119124423
4.. Tsang T.S.,Abhayaratna W.P.,Barnes M.E.,Miyasaka Y.,Gersh B.J.,Bailey K.R.,Cha S.S.,Seward J.B.. Prediction of cardiovascular outcomes with left atrial size: Is volume superior to area or diameter?J. Am. Coll. Cardiol.Year: 2006471018102310.1016/j.jacc.2005.08.07716516087
5.. Laukkanen J.A.,Kurl S.,Eranen J.,Huttunen M.,Salonen J.T.. Left atrium size and the risk of cardiovascular death in middle-aged menArch. Intern. Med.Year: 20051651788179310.1001/archinte.165.15.178816087829
6.. Benjamin E.J.,D’Agostino R.B.,Belanger A.J.,Wolf P.A.,Levy D.. Left atrial size and the risk of stroke and death. The Framingham Heart StudyCirculationYear: 19959283584110.1161/01.CIR.92.4.8357641364
7.. Pozzoli M.,Capomolla S.,Sanarico M.,Pinna G.,Cobelli F.,Tavazzi L.. Doppler evaluations of left ventricular diastolic filling and pulmonary wedge pressure provide similar prognostic information in patients with systolic dysfunction after myocardial infarctionAm. Heart J.Year: 199512971672510.1016/0002-8703(95)90321-67900623
8.. Pagel P.S.,Kehl F.,Gare M.,Hettrick D.A.,Kersten J.R.,Warltier D.C.. Mechanical function of the left atrium: New insights based on analysis of pressure-volume relations and Doppler echocardiographyAnesthesiologyYear: 20039897599410.1097/00000542-200304000-0002712657862
9.. Mitchell J.H.,Shapiro W.. Atrial function and the hemodynamic consequences of atrial fibrillation in manAm. J. Cardiol.Year: 19692355656710.1016/0002-9149(69)90009-55781882
10.. Appleton C.P.,Hatle L.K.,Popp R.L.. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic studyJ. Am. Coll. Cardiol.Year: 19881242644010.1016/0735-1097(88)90416-03392336
11.. Stefanadis C.,Dernellis J.,Tsiamis E.,Toutouzas P.. Effects of pacing-induced and balloon coronary occlusion ischemia on left atrial function in patients with coronary artery diseaseJ. Am. Coll. Cardiol.Year: 19993368769610.1016/S0735-1097(98)00623-810080469
12.. Kagawa K.,Arakawa M.,Miwa H.,Noda T.,Nishigaki K.,Ito Y.,Hirakawa S.. Left atrial function during left ventricular diastole evaluated by left atrial angiography and left ventriculographyJ. Cardiol.Year: 1994243173258057244
13.. Toutouzas K.,Trikas A.,Pitsavos C.,Barbetseas J.,Androulakis A.,Stefanadis C.,Toutouzas P.. Echocardiographic features of left atrium in elite male athletesAm. J. Cardiol.Year: 1996781314131710.1016/S0002-9149(96)00622-48960602
14.. Kihara Y.,Sasayama S.,Miyazaki S.,Onodera T.,Susawa T.,Nakamura Y.,Fujiwara H.,Kawai C.. Role of the left atrium in adaptation of the heart to chronic mitral regurgitation in conscious dogsCirc. Res.Year: 19886254355310.1161/01.RES.62.3.5433342477
15.. Yoshida N.,Okamoto M.,Makita Y.,Nanba K.,Yoshizumi M.. Determinants of enhanced left atrial active emptying with aging: Left atrial preload, contractility or both?Intern. Med.Year: 20094898799210.2169/internalmedicine.48.206619525585
16.. Nakao T.,Shimizu M.,Sugihara N.,Kita Y.,Shimizu K.,Takeda R.. Preload dependency of left atrial pump function in hypertrophic cardiomyopathyJpn. Circ. J.Year: 199357475410.1253/jcj.57.478437341
17.. Stefanadis C.,Dernellis J.,Toutouzas P.. A clinical appraisal of left atrial functionEur. Heart J.Year: 200122223610.1053/euhj.1999.258111133207
18.. Williams J.F. Jr.,Sonnenblick E.H.,Braunwald E.. Determinants of atrial contractile force in the intact heartAm. J. Physiol.Year: 1965209106110685846906
19.. Triposkiadis F.,Tentolouris K.,Androulakis A.,Trikas A.,Toutouzas K.,Kyriakidis M.,Gialafos J.,Toutouzas P.. Left atrial mechanical function in the healthy elderly: New insights from a combined assessment of changes in atrial volume and transmitral flow velocityJ. Am. Soc. Echocardiogr.Year: 1995880180910.1016/S0894-7317(05)80004-58611280
20.. Sunagawa K.,Maughan W.L.,Burkhoff D.,Sagawa K.. Left ventricular interaction with arterial load studied in isolated canine ventricleAm. J. Physiol.Year: 1983245H773H7806638199
21.. Stone H.L.. Effect of heart rate on left atrial systolic shortening in the dogJ. Appl. Physiol.Year: 197538111011161141126
22.. Schabelman S.,Schiller N.B.,Silverman N.H.,Ports T.A.. Left atrial volume estimation by two-dimensional echocardiographyCatheter. Cardiovasc. Diagn.Year: 1981716517810.1002/ccd.1810070206
23.. Prioli A.,Marino P.,Lanzoni L.,Zardini P.. Increasing degrees of left ventricular filling impairment modulate left atrial function in humansAm. J. Cardiol.Year: 19988275676110.1016/S0002-9149(98)00452-49761086
24.. Payne R.M.,Stone H.L.,Engelken E.J.. Atrial function during volume loadingJ. Appl. Physiol.Year: 1971313263315111850
25.. Okamoto M.,Tsubokura T.,Morishita K.,Nakagawa H.,Yamagata T.,Kawagoe T.,Hondo T.,Tsuchioka Y.,Matsuura H.,Kajiyama G.. Effects of volume loading on left atrial systolic time intervalsJ. Clin. UltrasoundYear: 19911940541110.1002/jcu.18701907071719035
26.. Blondheim D.S.,Osipov A.,Meisel S.R.,Frimerman A.,Shochat M.,Shotan A.. Relation of left atrial size to function as determined by transesophageal echocardiographyAm. J. Cardiol.Year: 20059645746310.1016/j.amjcard.2005.03.10116054483
27.. Abhayaratna W.P.,Fatema K.,Barnes M.E.,Seward J.B.,Gersh B.J.,Bailey K.R.,Casaclang-Verzosa G.,Tsang T.S.. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons > or = 65 years of ageAm. J. Cardiol.Year: 20081011626162910.1016/j.amjcard.2008.01.05118489941
28.. Gutman J.,Wang Y.S.,Wahr D.,Schiller N.B.. Normal left atrial function determined by 2-dimensional echocardiographyAm. J. Cardiol.Year: 19835133634010.1016/S0002-9149(83)80061-76823848
29.. Thomas L.,Levett K.,Boyd A.,Leung D.Y.,Schiller N.B.,Ross D.L.. Compensatory changes in atrial volumes with normal aging: Is atrial enlargement inevitable?J. Am. Coll. Cardiol.Year: 2002401630163510.1016/S0735-1097(02)02371-912427416
30.. Boyd A.C.,Schiller N.B.,Leung D.,Ross D.L.,Thomas L.. Atrial dilation and altered function are mediated by age and diastolic function but not before the eighth decadeJACC Cardiovasc. ImagingYear: 2011423424210.1016/j.jcmg.2010.11.01821414570
31.. D’Ascenzi F.,Cameli M.,Lisi M.,Zacá V.,Natali B.,Malandrino A.,Benincasa S.,Catanese S.,Causarano A.,Mondillo S.. Left atrial remodeling in competitive adolescent soccer playersInt. J. Sports Med.Year: 20123379580110.1055/s-0032-130466022562745
32.. Verma A.,Kilicaslan F.,Adams J.R.,Hao S.,Beheiry S.,Minor S.,Ozduran V.,Claude Elayi S.,Martin D.O.,Schweikert R.A.,et al. Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: An echocardiography and cine computed tomography analysisJ. Cardiovasc. Electrophysiol.Year: 20061774174610.1111/j.1540-8167.2006.00488.x16836670
33.. Rodrigues A.C.,Scannavacca M.I.,Caldas M.A.,Hotta V.T.,Pisani C.,Sosa E.A.,Mathias W. Jr.. Left atrial function after ablation for paroxysmal atrial fibrillationAm. J. Cardiol.Year: 200910339539810.1016/j.amjcard.2008.09.09419166696
34.. Tsao H.M.,Hu W.C.,Wu M.H.,Tai C.T.,Chang S.L.,Lin Y.J.,Lo L.W.,Huang C.C.,Hu Y.F.,Sheu M.H.,et al. The impact of catheter ablation on the dynamic function of the left atrium in patients with atrial fibrillation: Insights from four-dimensional computed tomographic imagesJ. Cardiovasc. Electrophysiol.Year: 20102127027710.1111/j.1540-8167.2009.01618.x19804542
35.. Hara H.,Virmani R.,Holmes D.R. Jr.,Buchbinder M.,Lesser J.R.,van Tassel R.A.,Mooney M.R.,Schwartz R.S.. Is the left atrial appendage more than a simple appendage?Catheter. Cardiovasc. Interv.Year: 20097423424219360867
36.. Johnson W.D.,Ganjoo A.K.,Stone C.D.,Srivyas R.C.,Howard M.. The left atrial appendage: Our most lethal human attachment—Surgical implicationsEur. J. Cardiothorac. Surg.Year: 20001771872210.1016/S1010-7940(00)00419-X10856866
37.. Akosah K.O.,Funai J.T.,Porter T.R.,Jesse R.L.,Mohanty P.K.. Left atrial appendage contractile function in atrial fibrillation. Influence of heart rate and cardioversion to sinus rhythmChestYear: 199510769069610.1378/chest.107.3.6907874938
38.. No authors listed. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at riskAnn. Intern. Med.Year: 199211661210.7326/0003-4819-116-1-61727097
39.. Gage B.F.,Waterman A.D.,Shannon W.,Boechler M.,Rich M.W.,Radford M.J.. Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillationJAMAYear: 20012852864287010.1001/jama.285.22.286411401607
40.. Boyd A.C.,McKay T.,Nasibi S.,Richards D.A.,Thomas L.. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillationEur. Heart J. Cardiovasc. ImagingYear: 20131426927510.1093/ehjci/jes15322833549
41.. Hoit B.D.,Shao Y.,Tsai L.M.,Patel R.,Gabel M.,Walsh R.A.. Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular fillingCirc. Res.Year: 19937216717510.1161/01.RES.72.1.1678417839
42.. Tabata T.,Oki T.,Yamada H.,Iuchi A.,Ito S.,Hori T.,Kitagawa T.,Kato I.,Kitahata H.,Oshita S.. Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgeryAm. J. Cardiol.Year: 19988132733210.1016/S0002-9149(97)00903-X9468076
43.. Davis C.A. III,Rembert J.C.,Greenfield J.C. Jr.. Compliance of left atrium with and without left atrium appendageAm. J. Physiol.Year: 1990259H1006H10082221109
44.. Chapeau C.,Gutkowska J.,Schiller P.W.,Milne R.W.,Thibault G.,Garcia R.,Genest J.,Cantin M.. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal speciesJ. Histochem. Cytochem.Year: 19853354155010.1177/33.6.31586983158698
45.. Kappagoda C.T.,Linden R.J.,Saunders D.A.. The effect on heart rate of distending the atrial appendages in the dogJ. Physiol.Year: 19722257057195076395
46.. Henry J.P.,Gauer O.H.,Reeves J.L.. Evidence of the atrial location of receptors influencing urine flowCirc. Res.Year: 19564859010.1161/01.RES.4.1.8513277115
47.. Fatkin D.,Feneley M.. Stratification of thromboembolic risk of atrial fibrillation by transthoracic echocardiography and transesophageal echocardiography: The relative role of left atrial appendage function, mitral valve disease, and spontaneous echocardiographic contrastProg. Cardiovasc. Dis.Year: 199639576810.1016/S0033-0620(96)80041-78693096
48.. Handke M.,Harloff A.,Hetzel A.,Olschewski M.,Bode C.,Geibel A.. Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: Determinants and relationship to spontaneous echocontrast and thrombus formation—A transesophageal echocardiographic study in 500 patients with cerebral ischemiaJ. Am. Soc. Echocardiogr.Year: 2005181366137210.1016/j.echo.2005.05.00616376768
49.. Panagiotopoulos K.,Toumanidis S.,Saridakis N.,Vemmos K.,Moulopoulos S.. Left atrial and left atrial appendage functional abnormalities in patients with cardioembolic stroke in sinus rhythm and idiopathic atrial fibrillationJ. Am. Soc. Echocardiogr.Year: 19981171171910.1053/je.1998.v11.a910269692528
50.. Alli O.,Doshi S.,Kar S.,Reddy V.,Sievert H.,Mullin C.,Swarup V.,Whisenant B.,Holmes D. Jr.. Quality of life assessment in the randomized PROTECT AF (percutaneous closure of the left atrial appendage versus Warfarin therapy for prevention of stroke in patients with atrial fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillationJ. Am. Coll. Cardiol.Year: 2013611790179810.1016/j.jacc.2013.01.06123500276
51.. Tavi P.,Han C.,Weckstrom M.. Mechanisms of stretch-induced changes in [Ca2+]i in rat atrial myocytes: Role of increased troponin C affinity and stretch-activated ion channelsCirc. Res.Year: 1998831165117710.1161/01.RES.83.11.11659831710
52.. Henry W.L.,Gardin J.M.,Ware J.H.. Echocardiographic measurements in normal subjects from infancy to old ageCirculationYear: 1980621054106110.1161/01.CIR.62.5.10547418156
53.. Kircher B.,Abbott J.A.,Pau S.,Gould R.G.,Himelman R.B.,Higgins C.B.,Lipton M.J.,Schiller N.B.. Left atrial volume determination by biplane two-dimensional echocardiography: Validation by cine computed tomographyAm. Heart J.Year: 199112186487110.1016/0002-8703(91)90200-22000754
54.. Hsiao S.H.,Huang W.C.,Lin K.L.,Chiou K.R.,Kuo F.Y.,Lin S.K.,Cheng C.C.. Left atrial distensibility and left ventricular filling pressure in acute versus chronic severe mitral regurgitationAm. J. Cardiol.Year: 201010570971510.1016/j.amjcard.2009.10.05220185021
55.. Oki T.,Tabata T.,Yamada H.,Fukuda K.,Abe M.,Onose Y.,Wakatsuki T.,Iuchi A.,Ito S.. Assessment of abnormal left atrial relaxation by transesophageal pulsed Doppler echocardiography of pulmonary venous flow velocityClin. Cardiol.Year: 19982175375810.1002/clc.49602110119789697
56.. Hoit B.D.,Shao Y.,Gabel M.,Walsh R.A.. Influence of pericardium on left atrial compliance and pulmonary venous flowAm. J. Physiol.Year: 1993264H1781H17878322906
57.. Parmley W.W.. Neuroendocrine changes in heart failure and their clinical relevanceClin. Cardiol.Year: 19951844044510.1002/clc.49601808047586761
58.. Brilla C.G.,Reams G.P.,Maisch B.,Weber K.T.. Renin-angiotensin system and myocardial fibrosis in hypertension: Regulation of the myocardial collagen matrixEur. Heart J.Year: 199314576110.1093/eurheartj/14.1.578281964
59.. Brilla C.G.,Matsubara L.S.,Weber K.T.. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronismJ. Mol. Cell. Cardiol.Year: 19932556357510.1006/jmcc.1993.10668377216
60.. Casaclang-Verzosa G.,Gersh B.J.,Tsang T.S.. Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillationJ. Am. Coll. Cardiol.Year: 20085111110.1016/j.jacc.2007.09.02618174029
61.. Dietz J.R.. Mechanisms of atrial natriuretic peptide secretion from the atriumCardiovasc. Res.Year: 20056881710.1016/j.cardiores.2005.06.00815993390
62.. Francis G.S.. Neuroendocrine activity in congestive heart failureAm. J. Cardiol.Year: 199066333810.1016/0002-9149(90)90474-F
63.. Tsioufis C.,Stougiannos P.,Taxiarchou E.,Skiadas I.,Chatzis D.,Thomopoulos C.,Lalos S.,Stefanadis C.,Kallikazaros I.. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertensionJ. Hypertens.Year: 20062496597210.1097/01.hjh.0000222768.15100.0016612260
64.. Weber K.T.,Brilla C.G.,Campbell S.E.,Guarda E.,Zhou G.,Sriram K.. Myocardial fibrosis: Role of angiotensin II and aldosteroneBasic Res. Cardiol.Year: 1993881071248395170
65.. Leistad E.,Christensen G.,Ilebekk A.. Significance of increased atrial pressure on stroke volume during atrial fibrillation in anaesthetized pigsActa Physiol. Scand.Year: 199314915716110.1111/j.1748-1716.1993.tb09608.x8266805
66.. Leistad E.,Christensen G.,Ilebekk A.. Effects of atrial fibrillation on left and right atrial dimensions, pressures, and compliancesAm. J. Physiol.Year: 1993264H1093H10978476085
67.. Henry W.L.,Morganroth J.,Pearlman A.S.,Clark C.E.,Redwood D.R.,Itscoitz S.B.,Epstein S.E.. Relation between echocardiographically determined left atrial size and atrial fibrillationCirculationYear: 19765327327910.1161/01.CIR.53.2.273128423
68.. Takahashi N.,Imataka K.,Seki A.,Fujii J.. Left atrial enlargement in patients with paroxysmal atrial fibrillationJpn. Heart J.Year: 19822367768310.1536/ihj.23.6777176076
69.. Suarez G.S.,Lampert S.,Ravid S.,Lown B.. Changes in left atrial size in patients with lone atrial fibrillationClin. Cardiol.Year: 19911465265610.1002/clc.49601408061914268
70.. Caplan L.R.,D’Cruz I.,Hier D.B.,Reddy H.,Shah S.. Atrial size, atrial fibrillation, and strokeAnn. Neurol.Year: 19861915816110.1002/ana.4101902083963758
71.. Sanfilippo A.J.,Abascal V.M.,Sheehan M.,Oertel L.B.,Harrigan P.,Hughes R.A.,Weyman A.E.. Atrial enlargement as a consequence of atrial fibrillation: A prospective echocardiographic studyCirculationYear: 19908279279710.1161/01.CIR.82.3.7922144217
72.. Klein A.L.,Grimm R.A.,Murray R.D.,Apperson-Hansen C.,Asinger R.W.,Black I.W.,Davidoff R.,Erbel R.,Halperin J.L.,Orsinelli D.A.,et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillationN. Engl. J. Med.Year: 20013441411142010.1056/NEJM20010510344190111346805
73.. Yu C.M.,Khattab A.A.,Bertog S.C.,Lee A.P.,Kwong J.S.,Sievert H.,Meier B.. Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillationNat. Rev. Cardiol.Year: 20131070772210.1038/nrcardio.2013.15824145892
74.. Stollberger C.,Schneider B.,Finsterer J.. Elimination of the left atrial appendage to prevent stroke or embolism? Anatomic, physiologic, and pathophysiologic considerationsChestYear: 20031242356236210.1378/chest.124.6.235614665520
75.. Keren G.,Etzion T.,Sherez J.,Zelcer A.A.,Megidish R.,Miller H.I.,Laniado S.. Atrial fibrillation and atrial enlargement in patients with mitral stenosisAm. Heart J.Year: 19871141146115510.1016/0002-8703(87)90190-62960225
76.. Boudoulas H.,Boudoulas D.,Sparks E.A.,Pearson A.C.,Nagaraja H.N.,Wooley C.F.. Left atrial performance indices in chronic mitral valve diseaseJ. Heart Valve Dis.Year: 19954S242S2478564003
77.. Sanada H.,Shimizu M.,Shimizu K.,Kita Y.,Sugihara N.,Takeda R.. Left atrial afterload mismatch in hypertrophic cardiomyopathyAm. J. Cardiol.Year: 1991681049105410.1016/0002-9149(91)90494-61927918
78.. Cioffi G.,Mureddu G.F.,Stefenelli C.,de Simone G.. Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertensionJ. Hypertens.Year: 2004221589159610.1097/01.hjh.0000125454.28861.7615257183
79.. Lakatta E.G.. Similar myocardial effects of aging and hypertensionEur. Heart J.Year: 199011293810.1093/eurheartj/11.suppl_G.291981552
80.. Vaziri S.M.,Larson M.G.,Lauer M.S.,Benjamin E.J.,Levy D.. Influence of blood pressure on left atrial size: The framingham heart studyHypertensionYear: 1995251155116010.1161/01.HYP.25.6.11557768556
81.. Dreslinski G.R.,Frohlich E.D.,Dunn F.G.,Messerli F.H.,Suarez D.H.,Reisin E.. Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: Atrial emptying indexAm. J. Cardiol.Year: 1981471087109010.1016/0002-9149(81)90217-46452811
82.. Healey J.S.,Connolly S.J.. Atrial fibrillation: Hypertension as a causative agent, risk factor for complications, and potential therapeutic targetAm. J. Cardiol.Year: 2003919G14G10.1016/S0002-9149(03)00227-3
83.. Tsang T.S.,Barnes M.E.,Gersh B.J.,Bailey K.R.,Seward J.B.. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burdenAm. J. Cardiol.Year: 2002901284128910.1016/S0002-9149(02)02864-312480035
84.. Matsuda M.,Matsuda Y.. Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertensionClin. Cardiol.Year: 19961995495910.1002/clc.49601912118957600
85.. Gerdts E.,Oikarinen L.,Palmieri V.,Otterstad J.E.,Wachtell K.,Boman K.,Dahlöf B.,Devereux R.B.,Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) StudyCorrelates of left atrial size in hypertensive patients with left ventricular hypertrophy: The losartan intervention for endpoint reduction in hypertension (LIFE) studyHypertensionYear: 20023973974310.1161/hy0302.10568311897755
86.. Boyd A.C.,Eshoo S.,Richards D.A.,Thomas L.. Hypertension accelerates the “normal” aging process with a premature increase in left atrial volumeJ. Am. Soc. Hypertens.Year: 2013714915610.1016/j.jash.2012.12.00823428410
87.. Kokubu N.,Yuda S.,Tsuchihashi K.,Hashimoto A.,Nakata T.,Miura T.,Ura N.,Nagao K.,Tsuzuki M.,Wakabayashi C.,et al. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: A possible beneficial effect of renin-angiotensin system inhibition on left atrial functionHypertens. Res.Year: 200730132110.1291/hypres.30.1317460367
88.. Sigwart U.,Grbic M.,Goy J.J.,Kappenberger L.. Left atrial function in acute transient left ventricular ischemia produced during percutaneous transluminal coronary angioplasty of the left anterior descending coronary arteryAm. J. Cardiol.Year: 19906528228610.1016/0002-9149(90)90288-C2301255
89.. Rahimtoola S.H.,Ehsani A.,Sinno M.Z.,Loeb H.S.,Rosen K.M.,Gunnar R.M.. Left atrial transport function in myocardial infarction: Importance of its booster-pump functionAm. J. Med.Year: 19755968669410.1016/0002-9343(75)90229-61200036
90.. Keren A.,DeAnda A.,Komeda M.,Tye T.,Handen C.R.,Daughters G.T.,Ingels N.B.,Miller C.,Popp R.L.,Nikolic S.D.. Pitfalls in creation of left atrial pressure-area relationships with automated border detectionJ. Am. Soc. Echocardiogr.Year: 1995866967810.1016/S0894-7317(05)80381-59417210
91.. Gibson D.G.,Francis D.P.. Clinical assessment of left ventricular diastolic functionHeartYear: 20038923123810.1136/heart.89.2.23112527689
92.. Wierzbowska-Drabik K.,Krzeminska-Pakula M.,Drozdz J.,Plewka M.,Trzos E.,Kurpesa M.,Rechciński T.,Rózga A.,Plońska-Gościniak E.,Kasprzak J.D.. Enlarged left atrium is a simple and strong predictor of poor prognosis in patients after myocardial infarctionEchocardiographyYear: 200825273518186777
93.. Hoit B.D.,Shao Y.,Gabel M.,Walsh R.A.. Left atrial mechanical and biochemical adaptation to pacing induced heart failureCardiovasc. Res.Year: 19952946947410.1016/0008-6363(96)88521-X7796439
94.. D’Andrea A.,Caso P.,Romano S.,Scarafile R.,Riegler L.,Salerno G.,Limongelli G.,di Salvo G.,Calabrò P.,del Viscovo L.,et al. Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: A two-dimensional speckle strain studyEur. Heart J.Year: 2007282738274810.1093/eurheartj/ehm44317959621
95.. Paraskevaidis I.A.,Panou F.,Papadopoulos C.,Farmakis D.,Parissis J.,Ikonomidis I.,Rigopoulos A.,Iliodromitis E.K.,Th Kremastinos D.. Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: A tissue Doppler imaging and two-dimensional strain studyHeartYear: 20099548348910.1136/hrt.2008.14654818765436
96.. Rosca M.,Popescu B.A.,Beladan C.C.,Calin A.,Muraru D.,Popa E.C.,Lancellotti P.,Enache R.,Coman I.M.,Jurcuţ R.,et al. Left atrial dysfunction as a correlate of heart failure symptoms in hypertrophic cardiomyopathyJ. Am. Soc. Echocardiogr.Year: 2010231090109810.1016/j.echo.2010.07.01620739145
97.. Shahar E.,Whitney C.W.,Redline S.,Lee E.T.,Newman A.B.,Nieto F.J.,O’Connor G.T.,Boland L.L.,Schwartz J.E.,Samet J.M.. Sleep-disordered breathing and cardiovascular diseaseAm. J. Respir. Crit. Care Med.Year: 2001163192510.1164/ajrccm.163.1.200100811208620
98.. Oliveira W.,Campos O.,Bezerra Lira-Filho E.,Cintra F.D.,Vieira M.,Ponchirolli A.,de Paola A.,Tufik S.,Poyares D.. Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three-dimensional echocardiographyJ. Am. Soc. Echocardiogr.Year: 2008211355136110.1016/j.echo.2008.09.00718930630


[Figure ID: ijms-15-15146-f001]
Figure 1 

The three integrated phases of left atrium (LA) function in relation to the electrocardiogram (ECG).

Article Categories:
  • Review

Keywords: left atrium, macrophysiology, phases, integrated, interactions.

Previous Document:  PL-PatchSurfer: A Novel Molecular Local Surface-Based Method for Exploring Protein-Ligand Interactio...
Next Document:  The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors.